Drug Profile
Baclofen/naltrexone/sorbitol - Pharnext
Alternative Names: (RS)-baclofen/D-sorbitol/naltrexone; (RS)-baclofen/naltrexone/D-sorbitol; Baclofen/sorbitol/naltrexone; Naltrexone/baclofen/sorbitol; Naltrexone/sorbitol/baclofen; PXT-03003; PXT-3003; Sorbitol/baclofen/naltrexone; Sorbitol/naltrexone/baclofen; SYNGILITYLatest Information Update: 28 Jan 2023
Price :
$50
*
At a glance
- Originator Pharnext
- Developer GeneNet; Pharnext
- Class Aminobutyric acids; Analgesics; Antispastics; Cyclopropanes; Ethers; Ketones; Morphinans; Muscle relaxants; Small molecules; Sugar alcohols
- Mechanism of Action GABA B receptor agonists; Opioid receptor antagonists; PMP22 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Charcot-Marie-Tooth disease